In 2023, the use of hypnotic and sedative medicine in Sweden stood at 68.5 DDD per thousand persons per day. The trend from 2013 to 2023 shows fluctuations, with sharp increases in 2017-2020, reaching a peak in 2020 at 70.2, followed by a slight decline in 2021-2022, and a rebound in 2023. The year-on-year variation was 1.48%, while the five-year CAGR was 2.41%.
Over the next five years, a steady increase is projected with a forecasted five-year CAGR of 1.1%, anticipating the usage to reach 73.4 by 2028, reflecting a 5.61% growth rate. Notable future trends to consider include the impact of aging populations, broader acceptance of mental health interventions, and potential changes in prescription regulations. Monitoring these elements will be crucial for predicting market dynamics.
